We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Manmeet Ahluwalia

Manmeet Ahluwalia MD, FACP

Dean and Diane Miller Family Endowed Chair in Neuro-Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute and Taussig Cancer Institute, Cleveland Clinic; Associate Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio

Biographical Sketch:

Dr. Manmeet Ahluwalia is the Dean and Diane Miller Family Endowed Chair in Neuro-Oncology in the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center (BBTC), Cleveland Clinic, where he subspecializes in treatment of patients with brain tumors and brain metastases. He is an Associate Professor in the Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is the Director of the Brain Metastasis Research Program and Head of Operations in the BBTC of the Neurological Institute of Cleveland Clinic. He is the Section Head of Neuro-Oncology Outcomes and Associate Director of Clinical Trials in BBTC, Cleveland Clinic, and has a joint appointment in the Developmental Therapeutics Program, Case Comprehensive Cancer Center.

After receiving his medical degree from Maulana Azad Medical College, University of Delhi, India, Dr. Ahluwalia underwent residency training in internal medicine at Fairview Hospital, Cleveland Clinic Health System, and completed fellowship training in hematology/oncology at the Roswell Park Cancer Institute, University of Buffalo in Buffalo, New York

Dr. Ahluwalia's research focuses on the development of new therapies for patients with brain tumors and brain metastases. He is currently leading several clinical trials involving new targeted therapies as well immunotherapeutic approaches. His research has been presented nationally and internationally and has resulted in over 90 editorials, peer-reviewed manuscripts, and book chapters.

Dr. Ahluwalia is a fellow in the American College of Physicians and has served in multiple leadership positions in the professional societies. He serves in editorial capacities for several journals, including Neurosurgery, ASCO Post, and HemOnc Today. He also serves on the editorial boards of Neuro-Oncology, Chinese Journal of Oncology, and the neuro-oncology section of the Frontiers in Oncology and Frontiers in Neurology.

Positions:

Dean and Diane Miller Family Endowed Chair in Neuro-Oncology, Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute and Taussig Cancer Institute, Cleveland Clinic; Associate Professor, Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio

Degrees:

MBBS: Maulana Azad Medical College, University of Delhi, India

Postgraduate Training:

Fellowship (hematology/oncology): Roswell Park Cancer Institute, University of Buffalo, Buffalo, New York

Research Interests: Novel treatments for brain tumors and brain metastases